Core Viewpoint - Faraday Future (FFAI.US) stock price declined over 8% to $1.625 following the announcement of a $41 million investment in Qualigen Therapeutics (QLGN.US) to support its entry into the crypto and Web3 sectors [1] Group 1: Company Actions - Faraday Future announced a $41 million investment in Qualigen Therapeutics to facilitate its expansion into the crypto and Web3 markets [1] - This investment will provide Faraday Future with significant equity in Qualigen and plans to appoint a management team to lead new business activities [1] Group 2: Market Reactions - Following the investment announcement, Qualigen Therapeutics' stock surged over 95%, reaching $5.55 [1]

Core Viewpoint - Faraday Future (FFAI.US) stock price declined over 8% to $1.625 following the announcement of a $41 million investment in Qualigen Therapeutics (QLGN.US) to support its entry into the crypto and Web3 sectors [1] Group 1 - Faraday Future's investment in Qualigen Therapeutics amounts to $41 million [1] - Following the investment announcement, Qualigen Therapeutics' stock surged over 95% to $5.55 [1] - The investment will provide Faraday Future with significant equity in Qualigen and plans to assign a management team to lead new business activities [1]